Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30995297 | 0.78 | NPSR1 (0.37) | TRPV4KMT2A | |
| SCHEMBL27213753 | 0.78 | NPSR1 (0.37) | TRPV4KMT2A | |
| SCHEMBL24723840 | 0.77 | TRPV4 (0.41) | TRPV4KMT2A | |
| SCHEMBL26674998 | 0.73 | CA2 (0.44) | KDM4EPOLBKMT2A | |
| SCHEMBL26675086 | 0.73 | KDM4E (0.34) | KDM4EPOLBKMT2A | |
| SCHEMBL29552227 | 0.73 | CA2 (0.44) | KDM4EPOLBKMT2A | |
| SCHEMBL29552743 | 0.73 | KDM4E (0.34) | KDM4EPOLBKMT2A | |
| SCHEMBL31064270 | 0.73 | KMT2A (0.54) | KDM4EPOLBKMT2A | |
| SCHEMBL30006632 | 0.71 | ASPH (0.50) | KDM4ETRPV4KMT2A | |
| SCHEMBL1173916 | 0.71 | ASPH (0.50) | KDM4ETRPV4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357152-A1 | USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS VIII | BASF SE (DE) | 2023-11-09 | — | — | US | disclosed |
| CN-116056576-A | Use of strobilurin type compounds for combating phytopathogenic fungi containing F129L amino acid substitutions conferring tolerance to Qo inhibitor VIII in mitochondrial cytochrome b proteins | 巴斯夫欧洲公司 | 2023-05-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357152-A1 | USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS VIII | COX5B, COX6B1, SQOR | KDM4E 2949/4885TRPV4 4843/4885POLB 330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.